Phase Ⅲ Randomized Trial in Postoperative Hepatocellular Carcinoma

PHASE3CompletedINTERVENTIONAL
Enrollment

268

Participants

Timeline

Start Date

October 31, 1997

Study Completion Date

July 31, 2005

Conditions
Hepatocellular Carcinoma
Interventions
DRUG

IFN-α2b

Trial Locations (1)

333

Chang Gung Memorial Hospital, Taoyuan District

All Listed Sponsors
collaborator

Chang Gung Memorial Hospital

OTHER

collaborator

Tri-Service General Hospital

OTHER

collaborator

National Taiwan University Hospital

OTHER

collaborator

Taipei Veterans General Hospital, Taiwan

OTHER_GOV

collaborator

Mackay Memorial Hospital

OTHER

collaborator

China Medical University Hospital

OTHER

lead

National Health Research Institutes, Taiwan

OTHER

NCT00149565 - Phase Ⅲ Randomized Trial in Postoperative Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter